国家中医药局:开创新时代中医药振兴发展新局面

2017-12-25 黄 蓓 中国中医

中医药学是中国古代科学的瑰宝,也是打开中华文明宝库的钥匙。当前,中医药振兴发展迎来天时、地利、人和的大好时机,希望广大中医药工作者增强民族自信,勇攀医学高峰,深入发掘中医药宝库中的精华,充分发挥中医药的独特优势,推进中医药现代化,推动中医药走向世界,切实把中医药这一祖先留给我们的宝贵财富继承好、发展好、利用好,在建设健康中国、实现中国梦的伟大征程中谱写新的篇章。

中医药学是中国古代科学的瑰宝,也是打开中华文明宝库的钥匙。当前,中医药振兴发展迎来天时、地利、人和的大好时机,希望广大中医药工作者增强民族自信,勇攀医学高峰,深入发掘中医药宝库中的精华,充分发挥中医药的独特优势,推进中医药现代化,推动中医药走向世界,切实把中医药这一祖先留给我们的宝贵财富继承好、发展好、利用好,在建设健康中国、实现中国梦的伟大征程中谱写新的篇章。——摘自习近平致中国中医科学院成立60周年贺信

12月22日,国家中医药管理局组织召开党组理论学习中心组(扩大)2017年第六次集体学习会议会议以“习近平总书记致信中国中医科学院两周年”为契机,组织深入学习贯彻习近平总书记关于中医药的新思想新论断新要求,推动把学习党的十九大精神和习近平新时代中国特色社会主义思想引向深入。国家卫生计生委副主任,国家中医药管理局党组书记、局长王国强主持会议并强调,要全面学习贯彻党的十九大精神,奋力开创新时代中医药振兴发展的新局面。

会上,王国强带领与会人员再次重温习近平总书记的贺信,并指出,贺信着眼于新的历史条件下振兴发展中医药,系统地阐述事关中医药发展的根本性、长远性的问题,要做到再认识、再学习、再提高、再部署、再奋进。党的十八大以来,以习近平同志为核心的党中央高度重视中医药工作,党的十九大部署实施健康中国战略,提出了“坚持中西医并重,传承发展中医药事业”的重要任务,对中医药工作做出了直接的、明确的部署,也提出了深层次、全方位的要求,必须全面贯彻党的十九大精神,以习近平新时代中国特色社会主义思想为指导,坚持以人民为中心的发展思想,坚持党对中医药工作的领导,积极适应社会主要矛盾的变化,推动中医药更有质量、更有效率、更可持续地发展。

王国强指出,要以增进人民群众中医药获得感作为工作的出发点和落脚点,深刻学习领会习近平总书记发展中医药的新思想新论断新要求,扎实推动习近平总书记的贺信精神和十九大精神在中医药系统落地生根,并转化为新时期的生动实践。

一要完善发展目标和路径。加强战略研究和宏观规划,进一步完善振兴发展中医药的战略目标和实施路径,确保中医药的发展目标任务与“两个一百年”的奋斗目标相一致、相协调。二要服务健康中国战略。在完善国民健康政策中,全方位落实中西医并重的方针,推动从法规、规划、政策、项目等方面一体谋划中医、西医的发展。三要抓好中医药法和中医药发展战略规划纲要实施。要继续在工作中学习好、宣传好、普及好中医药法,继续抓紧制定和执行推动中医药法落实的配套制度。四要深化中医药改革。深化中医药供给侧结构性改革,优化中医药服务供给水平和质量,大力发展中医药健康服务。五要提高发展质量和效益。坚持抓重点、补短板、强弱项,提升中医药发展的质量和水平。以提高中医临床疗效为核心,实施中医药传承创新工程建设项目、中医临床优势培育工程。

“中医药学是中国古代科学的瑰宝,也是打开中华文明宝库的钥匙”“切实把中医药这一祖先留给我们的宝贵财富继承好、发展好、利用好”,2015年12月18日,习近平总书记在祝贺中国中医科学院成立60周年的贺信中对中医药给予了高度评价,同时也对科研工作者提出了发展要求。两年来,广大中医药工作者以总书记贺信精神为指引,集中精力谋大事、抓大事、办成事。加强顶层设计,推动国务院印发《中医药发展战略规划纲要(2016—2030年)》等专项规划;坚持法治引领,推动中医药法及配套文件颁布实施;全面深化改革,统筹协调发展,中医药健康服务催生新业态,中医药科技创新成果涌现,中医药“走出去”步伐稳健。中国中医科学院认真贯彻落实总书记贺信精神,各项事业也取得了长足的进展。在科研体系构建方面,成立了青蒿素研究中心,启动了国家康复中心、国家针灸研究中心的建设;在重大科研项目方面,开展“抗生素中医药替代研究”,实施重大新药创制项目;在科技成果产出方面,获得新药证书1项,申请新药证书和临床批件各3项,国际权威刊物上发表了多篇有影响力的学术论文。

国家中医药管理局党组成员、副局长马建中、王志勇、闫树江,副局长于文明出席会议,局机关副司级以上干部、各直属单位领导班子成员以及中国中医科学院二级院所主要负责同志参加会议。局医政司、国合司、中国中医科学院、中国中医药出版社等主要负责同志作交流发言。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2077164, encodeId=801f20e71649b, content=<a href='/topic/show?id=af892152021' target=_blank style='color:#2F92EE;'>#中医药局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21520, encryptionId=af892152021, topicName=中医药局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Tue Oct 16 15:06:00 CST 2018, time=2018-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281003, encodeId=85c3281003b4, content=学了......., beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Mon Jan 22 16:35:17 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285504, encodeId=7d05128550408, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Dec 27 08:06:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409255, encodeId=5a3c14092555a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Dec 27 08:06:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582642, encodeId=23ab1582642c6, content=<a href='/topic/show?id=36455839121' target=_blank style='color:#2F92EE;'>#新时代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58391, encryptionId=36455839121, topicName=新时代)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Dec 27 08:06:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272487, encodeId=074f2e248782, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Mon Dec 25 21:56:41 CST 2017, time=2017-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272480, encodeId=fdb32e24802b, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Dec 25 21:38:16 CST 2017, time=2017-12-25, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2077164, encodeId=801f20e71649b, content=<a href='/topic/show?id=af892152021' target=_blank style='color:#2F92EE;'>#中医药局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21520, encryptionId=af892152021, topicName=中医药局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Tue Oct 16 15:06:00 CST 2018, time=2018-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281003, encodeId=85c3281003b4, content=学了......., beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Mon Jan 22 16:35:17 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285504, encodeId=7d05128550408, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Dec 27 08:06:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409255, encodeId=5a3c14092555a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Dec 27 08:06:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582642, encodeId=23ab1582642c6, content=<a href='/topic/show?id=36455839121' target=_blank style='color:#2F92EE;'>#新时代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58391, encryptionId=36455839121, topicName=新时代)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Dec 27 08:06:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272487, encodeId=074f2e248782, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Mon Dec 25 21:56:41 CST 2017, time=2017-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272480, encodeId=fdb32e24802b, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Dec 25 21:38:16 CST 2017, time=2017-12-25, status=1, ipAttribution=)]
    2018-01-22 135****7952平儿

    学了.......

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2077164, encodeId=801f20e71649b, content=<a href='/topic/show?id=af892152021' target=_blank style='color:#2F92EE;'>#中医药局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21520, encryptionId=af892152021, topicName=中医药局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Tue Oct 16 15:06:00 CST 2018, time=2018-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281003, encodeId=85c3281003b4, content=学了......., beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Mon Jan 22 16:35:17 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285504, encodeId=7d05128550408, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Dec 27 08:06:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409255, encodeId=5a3c14092555a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Dec 27 08:06:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582642, encodeId=23ab1582642c6, content=<a href='/topic/show?id=36455839121' target=_blank style='color:#2F92EE;'>#新时代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58391, encryptionId=36455839121, topicName=新时代)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Dec 27 08:06:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272487, encodeId=074f2e248782, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Mon Dec 25 21:56:41 CST 2017, time=2017-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272480, encodeId=fdb32e24802b, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Dec 25 21:38:16 CST 2017, time=2017-12-25, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2077164, encodeId=801f20e71649b, content=<a href='/topic/show?id=af892152021' target=_blank style='color:#2F92EE;'>#中医药局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21520, encryptionId=af892152021, topicName=中医药局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Tue Oct 16 15:06:00 CST 2018, time=2018-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281003, encodeId=85c3281003b4, content=学了......., beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Mon Jan 22 16:35:17 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285504, encodeId=7d05128550408, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Dec 27 08:06:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409255, encodeId=5a3c14092555a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Dec 27 08:06:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582642, encodeId=23ab1582642c6, content=<a href='/topic/show?id=36455839121' target=_blank style='color:#2F92EE;'>#新时代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58391, encryptionId=36455839121, topicName=新时代)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Dec 27 08:06:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272487, encodeId=074f2e248782, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Mon Dec 25 21:56:41 CST 2017, time=2017-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272480, encodeId=fdb32e24802b, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Dec 25 21:38:16 CST 2017, time=2017-12-25, status=1, ipAttribution=)]
    2017-12-27 cathymary
  5. [GetPortalCommentsPageByObjectIdResponse(id=2077164, encodeId=801f20e71649b, content=<a href='/topic/show?id=af892152021' target=_blank style='color:#2F92EE;'>#中医药局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21520, encryptionId=af892152021, topicName=中医药局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Tue Oct 16 15:06:00 CST 2018, time=2018-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281003, encodeId=85c3281003b4, content=学了......., beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Mon Jan 22 16:35:17 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285504, encodeId=7d05128550408, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Dec 27 08:06:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409255, encodeId=5a3c14092555a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Dec 27 08:06:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582642, encodeId=23ab1582642c6, content=<a href='/topic/show?id=36455839121' target=_blank style='color:#2F92EE;'>#新时代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58391, encryptionId=36455839121, topicName=新时代)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Dec 27 08:06:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272487, encodeId=074f2e248782, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Mon Dec 25 21:56:41 CST 2017, time=2017-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272480, encodeId=fdb32e24802b, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Dec 25 21:38:16 CST 2017, time=2017-12-25, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2077164, encodeId=801f20e71649b, content=<a href='/topic/show?id=af892152021' target=_blank style='color:#2F92EE;'>#中医药局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21520, encryptionId=af892152021, topicName=中医药局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Tue Oct 16 15:06:00 CST 2018, time=2018-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281003, encodeId=85c3281003b4, content=学了......., beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Mon Jan 22 16:35:17 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285504, encodeId=7d05128550408, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Dec 27 08:06:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409255, encodeId=5a3c14092555a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Dec 27 08:06:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582642, encodeId=23ab1582642c6, content=<a href='/topic/show?id=36455839121' target=_blank style='color:#2F92EE;'>#新时代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58391, encryptionId=36455839121, topicName=新时代)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Dec 27 08:06:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272487, encodeId=074f2e248782, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Mon Dec 25 21:56:41 CST 2017, time=2017-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272480, encodeId=fdb32e24802b, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Dec 25 21:38:16 CST 2017, time=2017-12-25, status=1, ipAttribution=)]
    2017-12-25 thlabcde

    好资料学习了!

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2077164, encodeId=801f20e71649b, content=<a href='/topic/show?id=af892152021' target=_blank style='color:#2F92EE;'>#中医药局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21520, encryptionId=af892152021, topicName=中医药局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Tue Oct 16 15:06:00 CST 2018, time=2018-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281003, encodeId=85c3281003b4, content=学了......., beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Mon Jan 22 16:35:17 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285504, encodeId=7d05128550408, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Dec 27 08:06:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409255, encodeId=5a3c14092555a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Dec 27 08:06:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582642, encodeId=23ab1582642c6, content=<a href='/topic/show?id=36455839121' target=_blank style='color:#2F92EE;'>#新时代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58391, encryptionId=36455839121, topicName=新时代)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Dec 27 08:06:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272487, encodeId=074f2e248782, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Mon Dec 25 21:56:41 CST 2017, time=2017-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272480, encodeId=fdb32e24802b, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Dec 25 21:38:16 CST 2017, time=2017-12-25, status=1, ipAttribution=)]
    2017-12-25 惠映实验室

    学习了.谢谢.

    0

相关资讯

国家中医药局:推动十九大精神在中医药系统扎根开花结果

会议指出,十九大报告作出“坚持中西医并重,传承发展中医药事业”的重要部署,充分体现了以习近平同志为核心的党中央对中医药发展的高度重视,为我们在新时代推动中医药振兴发展提供了遵循、指明了方向。我们倍感振奋、深受鼓舞,更加感到任务艰巨、使命光荣。

国家中医药局直属机关党纪委支部进一步学习贯彻十九大精神

10月30日,国家中医药管理局直属机关党纪委支部召开支部党员大会,进一步学习党的十九大精神。会上,国家中医药管理局副局长、机关党委书记闫树江强调,十九大的最大亮点和最重要的历史贡献,是确立了习近平新时代中国特色社会主义思想的历史地位,实现了党的指导思想又一次与时俱进。党纪委支部全体同志要深入学习领会习近平新时代中国特色社会主义思想的时代背景、科学体系,深入学习领会习近平新时代中国特色社会主义思想的

国家中医药局2017年新闻宣传工作协调会议:围绕主旋律,传播正能量

10月13日,国家中医药管理局2017年新闻宣传工作协调会议召开。会议回顾总结了2017年前三季度中医药新闻宣传工作情况,并就做好下一步新闻宣传工作进行交流讨论,提出建议。国家中医药管理局副局长马建中肯定了今年以来中医药新闻宣传工作取得的成果,强调要进一步提升对新闻宣传工作重要性认识的高度,中医药事业是社会主义事业的组成部分,中医药新闻宣传要注重意识形态问题,要围绕主旋律,传播正能量。

国家中医药局学习党的十九大精神培训班开班:牢记使命,扎实传承发展中医药

11月16日,国家中医药管理局学习党的十九大精神培训班在中国中医科学院东区会议中心开班。国家卫生计生委副主任,国家中医药管理局党组书记、局长王国强作动员报告指出,要紧密结合中医药工作实际,推进十九大的重大决策部署落到实处、取得实效。国家中医药管理局党组成员、副局长闫树江主持开班仪式。

国家中医药局组织青年学习十九大精神

为学习贯彻党的十九大精神,用习近平新时代中国特色社会主义思想武装广大团员青年,11月23日,国家中医药管理局直属机关团委召开局机关和直属单位青年座谈会,组织青年代表交流学习党的十九大精神。